Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Pharmacological Research
|
December 19, 2016
New approaches to target glycinergic neurotransmission for the treatment of chronic pain
Wendy L Imlach
Medicines (Basel, Switzerland)
|
August 25, 2019
Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
Pawan Bista, Wendy L Imlach
Iscience
|
April 20, 2026
Microbiome-derived metabolites alleviate chronic pain in a reserpine-induced model of fibromyalgia
Shen Chen, Dhanya Shanmuganathan, Wendy L Imlach
European Journal of Pharmacology
|
February 13, 2009
Structural determinants of lolitrems for inhibition of BK large conductance Ca2+-activated K+ channels
Wendy L Imlach, Sarah C Finch, James Dunlop, et al.
Scientific Reports
|
November 15, 2016
Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain
Wendy L Imlach, Rebecca F Bhola, Sarasa A Mohammadi, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 9, 2011
Mechanism of action of lolitrem B, a fungal endophyte derived toxin that inhibits BK large conductance Ca²+-activated K+ channels
Wendy L Imlach, Sarah C Finch, Yanli Zhang, et al.
Molecular Pharmacology
|
June 25, 2015
A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model
Wendy L Imlach, Rebecca F Bhola, Lauren T May, et al.
Plos One
|
January 22, 2010
A role for BK channels in heart rate regulation in rodents
Wendy L Imlach, Sarah C Finch, John H Miller, et al.
Trends in Pharmacological Sciences
|
June 26, 2014
Glycine transport inhibitors for the treatment of pain
Robert J Vandenberg, Renae M Ryan, Jane E Carland, et al.
Cell
|
October 16, 2012
SMN is required for sensory-motor circuit function in Drosophila
Wendy L Imlach, Erin S Beck, Ben Jiwon Choi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Pharmacological Research
|
December 19, 2016
New approaches to target glycinergic neurotransmission for the treatment of chronic pain
Wendy L Imlach
Medicines (Basel, Switzerland)
|
August 25, 2019
Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
Pawan Bista, Wendy L Imlach
Iscience
|
April 20, 2026
Microbiome-derived metabolites alleviate chronic pain in a reserpine-induced model of fibromyalgia
Shen Chen, Dhanya Shanmuganathan, Wendy L Imlach
European Journal of Pharmacology
|
February 13, 2009
Structural determinants of lolitrems for inhibition of BK large conductance Ca2+-activated K+ channels
Wendy L Imlach, Sarah C Finch, James Dunlop, et al.
Scientific Reports
|
November 15, 2016
Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain
Wendy L Imlach, Rebecca F Bhola, Sarasa A Mohammadi, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 9, 2011
Mechanism of action of lolitrem B, a fungal endophyte derived toxin that inhibits BK large conductance Ca²+-activated K+ channels
Wendy L Imlach, Sarah C Finch, Yanli Zhang, et al.
Molecular Pharmacology
|
June 25, 2015
A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model
Wendy L Imlach, Rebecca F Bhola, Lauren T May, et al.
Plos One
|
January 22, 2010
A role for BK channels in heart rate regulation in rodents
Wendy L Imlach, Sarah C Finch, John H Miller, et al.
Trends in Pharmacological Sciences
|
June 26, 2014
Glycine transport inhibitors for the treatment of pain
Robert J Vandenberg, Renae M Ryan, Jane E Carland, et al.
Cell
|
October 16, 2012
SMN is required for sensory-motor circuit function in Drosophila
Wendy L Imlach, Erin S Beck, Ben Jiwon Choi, et al.
Page
of 3